Preferred Name |
Bevacizumab |
|
Synonyms |
|
|
Definitions |
A recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine. Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2039 |
|
definition |
A recombinant humanized monoclonal antibody directed against the vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine. Bevacizumab binds to VEGF and inhibits VEGF receptor binding, thereby preventing the growth and maintenance of tumor blood vessels. |
|
isDefinedBy | ||
label |
Bevacizumab |
|
prefixIRI |
ncit:C2039 |
|
prefLabel |
Bevacizumab |
|
seeAlso |
EuroCAT Umbrella Protocol for NSCLC |
|
subClassOf |
Create mapping